These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22479516)

  • 1. HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
    Hariri S; Steinau M; Rinas A; Gargano JW; Ludema C; Unger ER; Carter AL; Grant KL; Bamberg M; McDermott JE; Markowitz LE; Brewer NT; Smith JS
    PLoS One; 2012; 7(3):e34044. PubMed ID: 22479516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk Human Papillomavirus Determination in Formalin-fixed, Paraffin-embedded Cervical Tissue Using the Roche Cobas 4800 System: A Comparative Study With Liquid-based Cytology.
    Tardío JC; Cambero O; Sánchez-Estévez C; Sánchez-García AB; Angulo F; Moreno A
    Int J Gynecol Pathol; 2019 Jan; 38(1):11-16. PubMed ID: 29140880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.
    Castro FA; Koshiol J; Quint W; Wheeler CM; Gillison ML; Vaughan LM; Kleter B; van Doorn LJ; Chaturvedi AK; Hildesheim A; Schiffman M; Wang SS; Zuna RE; Walker JL; Dunn ST; Wentzensen N
    BMC Infect Dis; 2015 Nov; 15():544. PubMed ID: 26607224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the New INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens.
    Galan-Sanchez F; Hernández-Menendez M; De Los Rios Hernandez MA; Rodriguez-Iglesias M
    Acta Cytol; 2011; 55(4):341-3. PubMed ID: 21791903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onclarity Performance in Human Papillomavirus DNA Detection in Formalin-Fixed Paraffin-Embedded Cervical Samples.
    Bottari F; Passerini R; Renne G; Guerrieri ME; Sandri MT; Li A; Orlandini A; Iacobone AD
    J Low Genit Tract Dis; 2021 Jul; 25(3):216-220. PubMed ID: 34176913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women.
    Chinchai T; Chansaenroj J; Junyangdikul P; Swangvaree S; Karalak A; Niruthisard S; Poovorawan Y
    Asian Pac J Cancer Prev; 2011; 12(4):989-94. PubMed ID: 21790239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
    Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
    Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions.
    Brismar-Wendel S; Froberg M; Hjerpe A; Andersson S; Johansson B
    Br J Cancer; 2009 Aug; 101(3):511-7. PubMed ID: 19623178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
    J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.